Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Sleep Med. 2020 Sep 2;75:343–349. doi: 10.1016/j.sleep.2020.08.034

Table 2:

Comparison of symptoms within the last thirty days and symptoms at their worst, for those participants currently treated for idiopathic hypersomnia

Number (Percent) endorsing symptom at least daily, within the last 30 days Number (Percent) endorsing symptom at least daily, when symptoms were at their worst p-value*
Excessive daytime sleepiness 243 (64.1%) 370 (97.6%) <0.0001
Long sleep durations 52 (13.7%) 195 (51.5%) <0.0001
Intentional napping 52 (13.7%) 206 (54.4%) <0.0001
Unintentional daytime sleep 23 (6.1%) 140 (36.9%) <0.0001
Requiring multiple alarms to awaken 227 (60.2%) 265 (70.3%) <0.0001
Having trouble waking up and functioning with normal alertness 228 (61.1%) 301 (80.7%) <0.0001
Brain fog (being unable to think clearly or concentrate at any time throughout the day) 201 (54.0%) 311 (83.6%) <0.0001
Difficulty remembering things 189 (51.8%) 262 (71.8%) <0.0001
Automatic behaviors 42 (12.4%) 88 (26.0%) <0.0001

*p-values are for McNemar test between the two time points.